Search Results - "Pilc, A."

Refine Results
  1. 1

    The effect of physical activity on the brain derived neurotrophic factor: from animal to human studies by Zoladz, J A, Pilc, A

    “…It is well documented that physical activity can induce a number of various stimuli which are able to enhance the strength and endurance performance of…”
    Get more information
    Journal Article
  2. 2

    Comparative effectiveness of abatacept, apremilast, secukinumab and ustekinumab treatment of psoriatic arthritis: a systematic review and network meta-analysis by Kawalec, P., Holko, P., Moćko, P., Pilc, A.

    Published in Rheumatology international (01-02-2018)
    “…To assess the comparative effectiveness and safety of novel biologic therapies in psoriatic arthritis (PsA) and to establish the position of the non-anti-tumor…”
    Get full text
    Journal Article
  3. 3

    Endurance training increases plasma brain-derived neurotrophic factor concentration in young healthy men by Zoladz, J A, Pilc, A, Majerczak, J, Grandys, M, Zapart-Bukowska, J, Duda, K

    “…It is believed that brain derived neurotrophic factor (BDNF) plays an important role in neuronal growth, transmission, modulation and plasticity. Single bout…”
    Get more information
    Journal Article
  4. 4

    Neuroprotective effects of metabotropic glutamate receptor group II and III activators against MPP(+)-induced cell death in human neuroblastoma SH-SY5Y cells: The impact of cell differentiation state by Jantas, D., Greda, A., Golda, S., Korostynski, M., Grygier, B., Roman, A., Pilc, A., Lason, W.

    Published in Neuropharmacology (01-08-2014)
    “…Recent studies have documented that metabotropic glutamate receptors from group II and III (mGluR II/III) are a potential target in the symptomatic treatment…”
    Get full text
    Journal Article
  5. 5

    Neuroprotective effects of mGluR II and III activators against staurosporine- and doxorubicin-induced cellular injury in SH-SY5Y cells: New evidence for a mechanism involving inhibition of AIF translocation by Jantas, D., Greda, A., Leskiewicz, M., Grygier, B., Pilc, A., Lason, W.

    Published in Neurochemistry international (01-09-2015)
    “…•mGluR II/III activators showed better neuroprotective profile in undifferentiated SH-SY5Y cells.•Relatively the highest protection was mediated by mGluR8 and…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

    involvement of NMDA and AMPA receptors in the mechanism of antidepressant-like action of zinc in the forced swim test by Szewczyk, B, Poleszak, E, Sowa-Kućma, M, Wróbel, A, Słotwiński, S, Listos, J, Wlaź, P, Cichy, A, Siwek, A, Dybała, M, Gołembiowska, K, Pilc, A, Nowak, Gabriel

    Published in Amino acids (01-06-2010)
    “…Antidepressant-like activity of zinc in the forced swim test (FST) was demonstrated previously. Enhancement of such activity by joint administration of zinc…”
    Get full text
    Journal Article
  11. 11

    The reversal of cognitive, but not negative or positive symptoms of schizophrenia, by the mGlu2/3 receptor agonist, LY379268, is 5-HT1A dependent by Wierońska, Joanna M., Sławińska, A., Stachowicz, K., Łasoń-Tyburkiewicz, M., Gruca, P., Papp, M., Pilc, A.

    Published in Behavioural brain research (01-11-2013)
    “…•LY379268 is active in the model of cognitive symptoms of psychosis.•LY379268-induced reversal of cognitive symptoms of psychosis is…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Antidepressant‐like activity of CGP 36742 and CGP 51176, selective GABA B receptor antagonists, in rodents by Nowak, G, Partyka, A, Pałucha, A, Szewczyk, B, Wierońska, J M, Dybała, M, Metz, M, Librowski, T, Froestl, W, Papp, M, Pilc, A

    Published in British journal of pharmacology (29-01-2009)
    “…Background and purpose: A crucial role for the GABA B receptor in depression was proposed several years ago, but there are limited data to support this…”
    Get full text
    Journal Article
  14. 14

    Decreased sensitivity to paroxetine-induced inhibition of peripheral blood mononuclear cell growth in depressed and antidepressant treatment-resistant patients by Rzezniczek, S, Obuchowicz, M, Datka, W, Siwek, M, Dudek, D, Kmiotek, K, Oved, K, Shomron, N, Gurwitz, D, Pilc, A

    Published in Translational psychiatry (31-05-2016)
    “…Major depression disorder (MDD) is the most widespread mental disorder. Selective serotonin reuptake inhibitors (SSRIs) are used as first-line MDD treatment…”
    Get full text
    Journal Article
  15. 15

    The GABAB receptor agonist CGP44532 and the positive modulator GS39783 reverse some behavioural changes related to positive syndromes of psychosis in mice by Wierońska, JM, Kusek, M, Tokarski, K, Wabno, J, Froestl, W, Pilc, A

    Published in British journal of pharmacology (01-07-2011)
    “…BACKGROUND AND PURPOSE An important role of GABAergic neurotransmission in schizophrenia was proposed a long time ago, but there is limited data to support…”
    Get full text
    Journal Article
  16. 16
  17. 17

    The group III mGlu receptor agonist ACPT-I exerts anxiolytic-like but not antidepressant-like effects, mediated by the serotonergic and GABA-ergic systems by Stachowicz, K., Kłodzińska, A., Palucha-Poniewiera, A., Schann, S., Neuville, P., Pilc, A.

    Published in Neuropharmacology (01-09-2009)
    “…Our earlier studies have demonstrated that (1 S,3 R,4 S)-1-aminocyclo-pentane-1,3,4-tricarboxylic acid ACPT-I, a group III mGlu receptor agonist, produced…”
    Get full text
    Journal Article
  18. 18

    The influence of group III metabotropic glutamate receptor stimulation by (1S,3R,4S)-1-aminocyclo-pentane-1,3,4-tricarboxylic acid on the parkinsonian-like akinesia and striatal proenkephalin and prodynorphin mRNA expression in rats by Konieczny, J, Wardas, J, Kuter, K, Pilc, A, Ossowska, K

    Published in Neuroscience (16-03-2007)
    “…Abstract Group III metabotropic glutamate receptors (mGluRs) are widely distributed in the basal ganglia, especially on the terminals of pathways which seem to…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Potential anxiolytic‐ and antidepressant‐like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist by Tatarczyńska, Ewa, Kłodzińska, Aleksandra, Chojnacka‐Wójcik, Ewa, Pałucha, Agnieszka, Gasparini, Fabrizio, Kuhn, Rainer, Pilc, Andrzej

    Published in British journal of pharmacology (01-04-2001)
    “…Several lines of evidence suggest a crucial involvement of glutamate in the mechanism of action of anxiolytic and/or antidepressant drugs. The involvement of…”
    Get full text
    Journal Article